[ET Net News Agency, 23 August 2021] Sinopharm Group Co. Ltd. (01099) said its profit
attributable to owners of the parent was RMB3.58 billion for the six months ended 30 June
2021, a year-on-year increase of 23.73%. Basic earnings per share were RMB1.15. No
dividend will be distributed.
Revenue was RMB249.12 billion, a year-on-year increase of 22.26%. (RC)